Search research articles
Contact Us
Filters
Showing results (391-400 of 471) with videos related to
Page
of 48
Sort By:
Journal of Clinical Medicine
|
August 8, 2019
The Combination of Patient-Reported Clinical Symptoms and an Endoscopic Score Correlates Well with Health-Related Quality of Life in Patients with Ulcerative Colitis
Satimai Aniwan, David H Bruining, Sang Hyoung Park, et al.
Inflammatory Bowel Diseases
|
April 25, 2024
Reliability and Responsiveness of Clinical and Endoscopic Outcome Measures in Crohn's Disease
Reena Khanna, Brian G Feagan, Guangyong Zou, et al.
Inflammatory Bowel Diseases
|
March 10, 2018
Natural History of Established and De Novo Inflammatory Bowel Disease After Liver Transplantation for Primary Sclerosing Cholangitis
Mohamad A Mouchli, Siddharth Singh, Lisa Boardman, et al.
Radiology
|
January 27, 2006
Crohn Disease: mural attenuation and thickness at contrast-enhanced CT Enterography--correlation with endoscopic and histologic findings of inflammation
Kale D Bodily, Joel G Fletcher, Craig A Solem, et al.
AJR. American Journal of Roentgenology
|
June 23, 2009
Prospective comparison of state-of-the-art MR enterography and CT enterography in small-bowel Crohn's disease
Hassan A Siddiki, Jeff L Fidler, Joel G Fletcher, et al.
Inflammatory Bowel Diseases
|
August 27, 2013
Cytomegalovirus infection of the ileoanal pouch: clinical characteristics and outcomes
Jeffrey D McCurdy, Edward V Loftus, William J Tremaine, et al.
Gastroenterology
|
November 26, 2018
Efficacy and Safety of Abrilumab in a Randomized, Placebo-Controlled Trial for Moderate-to-Severe Ulcerative Colitis
William J Sandborn, Marcoli Cyrille, Mark Berner Hansen, et al.
The Lancet. Gastroenterology & Hepatology
|
November 19, 2021
Etrolizumab as induction and maintenance therapy for ulcerative colitis in patients previously treated with tumour necrosis factor inhibitors (HICKORY): a phase 3, randomised, controlled trial
Laurent Peyrin-Biroulet, Ailsa Hart, Peter Bossuyt, et al.
Journal of Crohn'S & Colitis
|
May 12, 2025
Deucravacitinib in patients with inflammatory bowel disease: 12-week efficacy and safety results from 3 randomized phase 2 studies in Crohn's disease and ulcerative colitis
Geert D'Haens, Silvio Danese, Remo Panaccione, et al.
Inflammatory Bowel Diseases
|
March 7, 2018
Postoperative Outcomes in Vedolizumab-Treated Patients Undergoing Major Abdominal Operations for Inflammatory Bowel Disease: Retrospective Multicenter Cohort Study
Amy L Lightner, Kellie L Mathis, Chung Sang Tse, et al.
Page
of 48
Search research articles
Search
Showing results (391-400 of 471) with videos related to
Sort By:
Page
of 48
Journal of Clinical Medicine
|
August 8, 2019
The Combination of Patient-Reported Clinical Symptoms and an Endoscopic Score Correlates Well with Health-Related Quality of Life in Patients with Ulcerative Colitis
Satimai Aniwan, David H Bruining, Sang Hyoung Park, et al.
Inflammatory Bowel Diseases
|
April 25, 2024
Reliability and Responsiveness of Clinical and Endoscopic Outcome Measures in Crohn's Disease
Reena Khanna, Brian G Feagan, Guangyong Zou, et al.
Inflammatory Bowel Diseases
|
March 10, 2018
Natural History of Established and De Novo Inflammatory Bowel Disease After Liver Transplantation for Primary Sclerosing Cholangitis
Mohamad A Mouchli, Siddharth Singh, Lisa Boardman, et al.
Radiology
|
January 27, 2006
Crohn Disease: mural attenuation and thickness at contrast-enhanced CT Enterography--correlation with endoscopic and histologic findings of inflammation
Kale D Bodily, Joel G Fletcher, Craig A Solem, et al.
AJR. American Journal of Roentgenology
|
June 23, 2009
Prospective comparison of state-of-the-art MR enterography and CT enterography in small-bowel Crohn's disease
Hassan A Siddiki, Jeff L Fidler, Joel G Fletcher, et al.
Inflammatory Bowel Diseases
|
August 27, 2013
Cytomegalovirus infection of the ileoanal pouch: clinical characteristics and outcomes
Jeffrey D McCurdy, Edward V Loftus, William J Tremaine, et al.
Gastroenterology
|
November 26, 2018
Efficacy and Safety of Abrilumab in a Randomized, Placebo-Controlled Trial for Moderate-to-Severe Ulcerative Colitis
William J Sandborn, Marcoli Cyrille, Mark Berner Hansen, et al.
The Lancet. Gastroenterology & Hepatology
|
November 19, 2021
Etrolizumab as induction and maintenance therapy for ulcerative colitis in patients previously treated with tumour necrosis factor inhibitors (HICKORY): a phase 3, randomised, controlled trial
Laurent Peyrin-Biroulet, Ailsa Hart, Peter Bossuyt, et al.
Journal of Crohn'S & Colitis
|
May 12, 2025
Deucravacitinib in patients with inflammatory bowel disease: 12-week efficacy and safety results from 3 randomized phase 2 studies in Crohn's disease and ulcerative colitis
Geert D'Haens, Silvio Danese, Remo Panaccione, et al.
Inflammatory Bowel Diseases
|
March 7, 2018
Postoperative Outcomes in Vedolizumab-Treated Patients Undergoing Major Abdominal Operations for Inflammatory Bowel Disease: Retrospective Multicenter Cohort Study
Amy L Lightner, Kellie L Mathis, Chung Sang Tse, et al.
Page
of 48